Latest News

HSBC unveils $1bn buyback as profits mushroom on Hong Kong growth
HSBC Holdings PLC (LSE:HSBA) has unveiled a fresh $1 billion share buyback after first-half profit rose 23% to beat forecasts, supported by growth in net interest income and its wealth business. The A

The AMD Deal Makes Core Scientific A Strong Buy
I'm rating Core Scientific a Strong Buy with a price target of $28, implying a 40% upside potential. My main growth drivers are the CoreWeave ramp, the AMD Phase 1 contract, additional power monetizat

Trump warns Iran talks are ‘last chance' to end war — oil prices rise as Tehran denies negotiations
Washington and Tehran continue to deliver mixed messages on the nature of diplomatic efforts. Oil prices rise amid a lack of clarity after slumping on Monday.

Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript

Bradda Head lets solar developer build on part of Pennsylvania lithium lease
Bradda Head Lithium Ltd (AIM:BHL) has agreed to let a solar developer build a commercial power facility on part of its Pennsylvania brine lease while retaining its underlying mineral rights. The AIM-l

Ross Gerber Says Tesla Investors Are Excited for SpaceX's Earnings Because They 'Get Elon Twice a Quarter' as Musk Agrees SPCX Dip Is An 'Insane Opportunity'
Investor Ross Gerber thinks Tesla Inc. (NASDAQ:TSLA) investors have reason to be excited by the upcoming Space Exploration Technologies Corp. (NASDAQ:SPCX) earnings call scheduled to take place follow

BP profit more than doubles as Trump blasts Big Oil for ‘making too much money'
BP profit more than doubles as Trump blasts Big Oil for ‘making too much money'

Prologis Announces Recommended Acquisition of SEGRO plc
Combination expands Prologis' European platform and enhances long-term growth opportunities SAN FRANCISCO, Aug. 4, 2026 /PRNewswire/ -- Prologis, Inc. (NYSE: PLD) today announced that it has reached

AudioCodes Reports Second Quarter 2026 Results and Declares Semi-Annual Dividend of 20 cents per share
OR YEHUDA, Israel, Aug. 4, 2026 /PRNewswire/ -- Second Quarter Highlights Quarterly revenues increased by 3.1% year-over-year to $63 million; Quarterly services revenues increased by 6.2% year-over-y

Equinor ASA: Share buy-back – third tranche for 2026
Please see below information about transactions made under the third tranche of the 2026 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).

Pfizer Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Pfizer Inc. (NYSE:PFE) will release its second quarter earnings report before the opening bell on Tuesday, Aug. 4.

Ibotta, Inc. (IBTA) Q2 2026 Earnings Call Transcript
Ibotta, Inc. (IBTA) Q2 2026 Earnings Call Transcript

Offerpad Solutions Inc. (OPAD) Q2 2026 Earnings Call Transcript
Offerpad Solutions Inc. (OPAD) Q2 2026 Earnings Call Transcript

Lleida.net's quarterly EBITDA falls 27% amid shift to B2C
Madrid, 4 August.- Lleida.net (BME:LLN, EPA:ALLLN), a telecommunications operator and qualified digital trust service provider, posted EBITDA of €713,000 in the second quarter of 2026, 27% below the s

Coherent: The Mix Flipped To AI Optics, Yet The Stock Keeps Falling
Coherent Corp. is evolving from a cyclical component vendor to a vertically integrated photonics platform, driving higher margins and reduced cyclicality. Datacenter & Communications now dominates COH

ValuEngine Weekly Market Summary And Commentary
Markets posted a modestly positive week, with the broad S&P 500 and Nasdaq-100 ETFs gaining 1.05% and 0.87%, respectively, while small caps slipped 0.59%. Leadership was concentrated in Consumer Discr

Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 3 trial designed to demonstrate superiority of bexobrutideg versus pirtobrutinib in patients with relapsed/refractory CLL/SLL previously treated with a covalent BTK inhibitor Phase 3 trial desig

Press Release: Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease Paris, August 4, 2026. Sanofi today announced that the European Commission (EC) has a

Wix Reports Second Quarter 2026 Results
NEW YORK -- Wix.com Ltd. (Nasdaq: WIX) (the “Company”), today reported financial results for second quarter 2026. In addition, the Company provided its outlook for the third quarter and reiterated exp

IQM Quantum Computers Reports First Earnings as Public Company, Reporting First Half and Second Quarter 2026 Results, and Initiates FY 2026 Guidance Supported by Over EUR 102 million Order Backlog
IQM Quantum Computers Plc, Stock Exchange Release, Half year financial report August 4, 2026 at 08:00 (EEST) ESPOO, FINLAND | August 4, 2026 | IQM Quantum Computers Plc (Nasdaq: IQMX) (“IQM”, “IQM Qua